Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arvind K Pandey

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
The Journal of Clinical Investigation|August 28, 2025
A smooth muscle cell lncRNA controls angiogenesis in chronic limb-threatening ischemia through miR-143-3p/HHIP signalingMing Zhai, Anurag Jamaiyar, Jun Qian, et al.
The New England Journal of Medicine|September 1, 2025
Apixaban for Extended Treatment of Provoked Venous ThromboembolismGregory Piazza, Behnood Bikdeli, Arvind K Pandey, et al.
Thrombosis Research|January 14, 2026
Impact of enduring risk factors on efficacy and safety of extended anticoagulation for provoked venous thromboembolism: Post-hoc analysis of the HI-PRO trialMariana Pfeferman, Sina Rashedi, Arvind K Pandey, et al.
JCI Insight|April 24, 2019
Critical role of Interleukin 21 and T follicular helper cells in hypertension and vascular dysfunctionBethany L Dale, Arvind K Pandey, Yuhan Chen, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
The Journal of Clinical Investigation|August 28, 2025
A smooth muscle cell lncRNA controls angiogenesis in chronic limb-threatening ischemia through miR-143-3p/HHIP signalingMing Zhai, Anurag Jamaiyar, Jun Qian, et al.
The New England Journal of Medicine|September 1, 2025
Apixaban for Extended Treatment of Provoked Venous ThromboembolismGregory Piazza, Behnood Bikdeli, Arvind K Pandey, et al.
Thrombosis Research|January 14, 2026
Impact of enduring risk factors on efficacy and safety of extended anticoagulation for provoked venous thromboembolism: Post-hoc analysis of the HI-PRO trialMariana Pfeferman, Sina Rashedi, Arvind K Pandey, et al.
JCI Insight|April 24, 2019
Critical role of Interleukin 21 and T follicular helper cells in hypertension and vascular dysfunctionBethany L Dale, Arvind K Pandey, Yuhan Chen, et al.
Pageof 4